Clinical preferences and trends of anti-vascular endothelial growth factor treatments for diabetic macular edema in Japan-Reference-Cited by-同舟云学术

Clinical preferences and trends of anti-vascular endothelial growth factor treatments for diabetic macular edema in Japan

Published:2018-10-26 Issue:2 Volume:10 Page:475-483
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J Diabetes Investig

Author:

Sugimoto Masahiko¹^ORCID,Tsukitome Hideyuki¹,Okamoto Fumiki²,Oshika Tetsuro²,Ueda Tetsuo³,Niki Masanori⁴,Mitamura Yoshinori⁴,Ishikawa Hiroto⁵,Gomi Fumi⁵,Kitano Shigehiko⁶,Noma Hidetaka⁷,Shimura Masahiko⁷,Sonoda Shozo⁸,Sawada Osamu⁹,Ohji Masahito⁹,Harimoto Kozo¹⁰,Takeuchi Masaru¹⁰,Takamura Yoshihiro¹¹,Kondo Mineo¹,Sakamoto Taiji⁸

Affiliation:

1. Department of Ophthalmology; Mie University Graduate School of Medicine; Tsu Japan

2. Department of Ophthalmology; Faculty of Medicine; University of Tsukuba; Tsukuba Japan

3. Department of Ophthalmology; Nara Medical University; Kashihara Japan

4. Department of Ophthalmology; Institute of Biomedical Sciences; Tokushima University Graduate School; Tokushima Japan

5. Department of Ophthalmology; Hyogo College of Medicine; Nishinomiya Japan

6. Department of Ophthalmology; Tokyo Women's Medical University; Tokyo Japan

7. Department of Ophthalmology; Tokyo Medical University Hachioji Medical Center; Hachioji Japan

8. Department of Ophthalmology; Kagoshima University Graduate School of Medical and Dental Sciences; Sakuragaoka Japan

9. Department of Ophthalmology; Shiga University of Medical Science; Otsu Japan

10. Department of Ophthalmology; National Defense Medical College; Tokorozawa Japan

11. Department of Ophthalmology; Faculty of Medical Sciences; University of Fukui; Fukui Japan

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdi.12929/fullpdf

Reference34 articles.

1. Diabetic retinopathy;Cheung;Lancet,2010

2. The incidence of visual loss in a diabetic population;Moss;Ophthalmology,1988

3. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema;Elman;Ophthalmology,2010

4. Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study. READ-2 Study Group;Nguyen;Ophthalmology,2010

5. Real-world evidence - what is it and what can it tell us?;Sherman;N Engl J Med,2016

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biodegradable microspheres come into sight: A promising biomaterial for delivering drug to the posterior segment of the eyeball;Materials Today Bio;2024-08

2. Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in diabetic macular edema: 2-year results from the Japan subgroup of the phase 3 YOSEMITE trial;Japanese Journal of Ophthalmology;2024-07-31

3. Anti-VEGF therapy for the long-term management of diabetic macular edema: a treat-to-target strategy based on macular morphology;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-07-12

4. Treatment Effects of Switching to Faricimab in Eyes with Diabetic Macular Edema Refractory to Aflibercept;Medicina;2024-04-28

5. Characterization of the visually impaired patients with diabetes mellitus in Japan;Journal of Diabetes Investigation;2024-03-27